Skip to main content
ConductScienceScienceDex

James E Galvin

NIH Rank #170
Unclaimed recordClaim profile
  • Top 1% Funded
  • Program Leader
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Mentor

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2085729Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Neurology
  • Radiology
  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$15.4M
Full award amounts, FY2024
Award Records
8
Records listing this PI
Award-Linked Rank
#170
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for James E Galvin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing James E Galvin as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG080536-02R01
    A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)
    Eip Pharma, Inc.
    $8.1M
    award amount
  • 5R01AG071514-04R01
    Multicultural Community Dementia Screening
    University of Miami School of Medicine
    $2.6M
    award amount
  • 1U01AG084528-01U01
    IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
    Institute for Molecular Medicine
    $1.8M
    award amount
  • 5R01AG057681-05R01
    The LUCINDA Trial
    Weill Cornell Medicine
    $1.4M
    award amount
  • 5R01AG069765-05R01
    Digital Detection of Dementia Studies (D cubed Studies).
    Indiana University Indianapolis
    $939.3K
    award amount
  • 1T32AG081170-01A1T32
    Cross-disciplinary research opportunity for training in AD/ADRD science (CROSSROADS)
    University of Miami School of Medicine
    $277.7K
    award amount
  • 3R01AG080536-02S1R01
    A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)
    Eip Pharma, Inc.
    $250K
    award amount
  • 5P30AG059295-07P30
    Native Alzheimer Disease Resource Center for Minority Aging Research (NAD-RCMAR)
    University of Miami School of Medicine
    $62.1K
    award amount

Award organizations

Organizations that administered FY2024 awards listing James E Galvin as a PI.

Eip Pharma, Inc.
MA
$8.3M
2 grants
University of Miami School of Medicine
FL
$3M
3 grants
Institute for Molecular Medicine
CA
$1.8M
1 grant
Weill Cornell Medicine
NY
$1.4M
1 grant
Indiana University Indianapolis
IN
$939.3K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Eip Pharma, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #170
  8. 2024
    Entered Top 25% Nationally
    Ranked #170
  9. 2024
    Entered Top 10% Nationally
    Ranked #170
  10. 2024
    Entered Top 5% Nationally
    Ranked #170
  11. 2024
    Entered Top 1% Nationally
    Ranked #170
  12. 2025
    $25M Cumulative Funding
  13. 2025
    Multi-Institutional Research
    Awards at 5 institutions
  14. 2025
    R01 Grant Holder
  15. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as James E Galvin.

Girardin Jean-louis
University of Miami School of Medicine
3
shared awards
John Alam
Eip Pharma, Inc.
3
shared awards
Michael G Agadjanyan
Institute for Molecular Medicine
3
shared awards
Tatjana Rundek
University of Miami School of Medicine
3
shared awards
Astrid M Suchy-dicey
University of Miami School of Medicine
1
shared award
Craig S Atwood
Weill Cornell Medicine
1
shared award
Dedra S Buchwald
University of Miami School of Medicine
1
shared award
Duygu Tosun-turgut
Institute for Molecular Medicine
1
shared award
Lon S Schneider
Institute for Molecular Medicine
1
shared award
Malaz Boustani
Indiana University Indianapolis
1
shared award

Explore further

Find collaborators for James E Galvin

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →